The discretion of the President of Oita University Advanced solid tumors are exposed to hypoxic conditions over longer periods of time as they grow. Tumor hypoxia is a major factor that induces malignant progression, but most previous studies on tumor hypoxia were performed under short-term hypoxia for up to 72 hours and few studies have focused on tumor response to chronic hypoxic conditions. Here we show a molecular mechanism by which chronic hypoxia promotes invasive behavior in prostate cancer cells. We found that an epithelial-mesenchymal transition (EMT)-driving transcription factor, slug, is specifically upregulated under chronic hypoxia and promotes tumor cell migration and invasion. Unexpectedly, processes associated with EMT, such as loss of E-cadherin, are not observed under chronic hypoxia. Instead, expression of ephrin-B1, a ligand of Eph-related receptor tyrosine kinases, is markedly induced by slug through E-box motifs and promotes cell migration and invasion. Furthermore, slug and ephrin-B1 are highly coexpressed in chronic hypoxic cells of human prostate adenocarcinoma tissues after androgen deprivation, which is known to cause tumor hypoxia. Taken together, these results indicate that chronic hypoxia-induced slug promotes invasive behavior of prostate cancer cells by activating the expression of ephrin-B1. In addition, ephrin-B1 may be a novel therapeutic target in combination with androgen deprivation therapy for aggressive prostate cancer.
junction (AJ) protein, and cytokeratins are replaced by N-cadherin, a mesenchymal AJ protein, and vimentin. 7, 9 The replacement of E-cadherin with N-cadherin enables the epithelial cells to form homotypic interaction with stromal cells and it promotes their migration and invasion. 10 Transcription factors of the snail family, snail and slug, and of the twist family, Twist1 and Twist2, are major drivers of EMT and are known to repress expression of the E-cadherin gene. 9 Advanced solid tumors develop regions with low oxygen concentrations (hypoxia) as they grow. 11, 12 Oxygen delivery to solid tumors is reduced by deteriorating conditions for diffusion due to abnormal structure and function of the tumor microvessels and disturbed microcirculation. Tumor hypoxia is a major factor that induces malignant progression and is strongly associated with a poor clinical prognosis in a variety of cancers, including carcinoma of the head and neck, 13 carcinoma of the uterine cervix, 14 melanoma 15 and prostate adenocarcinoma. 16, 17 Several studies demonstrated that hypoxia promotes EMT by inducing the expression of EMT-driving transcription factors by hypoxia-inducible factor-1α. [18] [19] [20] Tumor cells in these studies were cultured under hypoxia for 18-72 hours (acute hypoxic condition), but most solid tumors found in cancer patients are exposed to hypoxic conditions over longer periods of time (chronic hypoxic condition).
11,12
Therefore, we have investigated how chronic hypoxia affects the progression of tumors using human prostate cancer cells. [21] [22] [23] In this study, we demonstrate that chronic hypoxia-induced slug, Yoshimi Homma, Fukushima Medical University, Japan. 26 Mutagenesis of the E-box motifs, E-box1 and E-box2, in the ephrin-B1 promoter was performed using the KOD-Plus Mutagenesis Kit (TOYOBO, Osaka, Japan) and mutated reporter plasmids were designated as pGL3-Basic-ephrin-B1 promoter-E1m (mutation in E-box1), −E2m (mutation in E-box2), and −E1mE2m (mutations in both Ebox1 and 2). The sequence of forward primers used for mutagenesis were as follows: E1m: 5′-gacaaagaccCCCGGGgcgaggccgg-3′; E2m:
5′-gactccgggtcCCCGGGcaagcagacag-3′. 
| Cell culture

| Migration and invasion assays
Cell migration and invasion assays were performed under normoxic cells that had migrated to the undersurface of the membranes were counted as previously described. 22 The average number of cells was calculated from 3 independent experiments performed in triplicate.
| Whole genome microarray and data analysis
Genome-wide expression profiling was performed using the Whole (ephrin-B1; Hs_EFNB1; QT00024143), and β-actin (Hs_ACTB; QT00095431). β-Actin mRNA quantification was used for normalization.
| Western blotting
Cells were lysed in lysis buffer as described previously. 22 
| RNAi experiments
The LNCaP/CH6M cells were transfected with siRNAs (20 nmol/L final concentration) using Lipofectamine RNAiMAX (Invitrogen). siRNA duplexes (Dharmacon, Little Chalfont, UK) used to target slug and ephrin-B1 mRNAs were as follows: slug, 5′-UCUCUCCUCUUUCCG-GAUA-3′, 5′-GCGAUGCCCAGUCUAGAAA-3′, 5′-ACAGCGAACUG-GACACACA-3′, 5′-GAAUGUCUCUCCUGCACAA-3′; ephrin-B1, 5′-CGACAUCAUCAUUCCCUUA-3′, 5′-GAAAUACGCUUUACCAUCA-3′, 5′-UCAAGAAGCACCAUGAUUA-3′, 5′-UCAAGAAGCACCAUGAUUA-3′, 5′-GAGACAAGCUGGACAUCAU-3′. The negative control siRNA (siScr, Stealth RNAi Negative Control Duplexes) was from Invitrogen.
| Immunofluorescence analysis
The LNCaP cells grown on chamber slides were fixed with 4%
paraformaldehyde followed by permeabilization with PBS plus 0.1%
Triton X-100. The cells were incubated with anti-E-cadherin rabbit Double staining was performed as described herein.
| Production of lentivirus and generation of stable cell lines
Lentiviruses carrying pLenti6.3/V5-DEST-ephrin-B1 or pLenti6.3/V5-DEST empty (control) were packaged with 293T cells using the ViraPower Lentiviral Expression System (Invitrogen). LNCaP cells were infected with the lentiviral particles and the ephrin-B1 control or overexpressing cell lines were selected using 10 μg/mL blasticidin (Invitrogen).
| Cell transfection and luciferase reporter assays
The LNCaP cells were seeded into 6-well plates ( System (Promega). The firefly luciferase activity was normalized to the Renilla luciferase activity.
| Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) was carried out using a ChIP-IT Express Enzymatic kit (Active Motif, Tokyo, Japan) according to manufacturer's instructions. DNA-bound proteins extracted from the LNCaP/ CH6M cells were immunoprecipitated with anti-slug mouse monoclonal IgG (Santa Cruz) or control mouse IgG (Santa Cruz). The DNA pulled down by ChIP was subjected to PCR amplification of the ephrin-B1 promoter regions containing E-box1 or E-box2. The primer sequences were as follows: E-box1-containing region: forward, 5′-GGTCTGAGCTATGG-GATCGAG-3′; reverse, 5′-GCATCCTGGACCGGAGAAG-3′; E-box2-containing region: forward, 5′-TCCCCCTCCCACTGTTCTCAC-3′;
reverse, 5′-CCTCGTCCAGTCCCACGTAA-3′.
| Statistical analysis
Data are expressed as mean ± SD. Statistical analysis was performed using Student's t test. P < 0.05 was considered statistically significant.
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| Chronic hypoxia promotes prostate cancer cell migration and invasion
Chronic hypoxia has been shown to promote invasive behavior of human prostate cancer cells, LNCaP. [21] [22] [23] Here, we confirmed that cell migration and invasion are increased under chronic hypoxic conditions by performing migration and invasion assays (Figure 1 ). Cell invasion under chronic hypoxia for >6 months (LNCaP/CH6M) was significantly increased by 24-fold compared with normoxia (LNCaP/ N), and 4-fold compared with acute hypoxia (LNCaP/AH).
| Chronic hypoxia specifically upregulates the expression of an EMT-driving transcription factor, slug
Given that EMT has been implicated in cell migration, invasion and initiation of metastasis, [4] [5] [6] [7] [8] we next analyzed the expression of major EMT-driving genes of the snail family, snail, slug, and Smuc; and of the twist family, Twist1 and Twist2. 9 In our previous study, we performed the genome-wide expression profiling to identify differentially expressed genes among LNCaP/N, LNCaP/AH, and LNCaP/ CH6M. 23 Using these profiling data, we found that expression of slug was specifically and strongly upregulated under chronic hypoxia 
| siRNA-mediated repression of slug strongly inhibits chronic hypoxia-induced cell migration and invasion
To demonstrate whether the upregulation of slug is required for chronic hypoxia-induced enhancement of cell migration and invasion, siRNA-mediated repression of slug was performed in LNCaP/CH6M cells. We first confirmed that there was reduced expression of slug in the slug siRNA-transfected LNCaP/CH6M cells (siSlug; Figure 3A ).
Knockdown of slug strongly inhibited migration and invasion of LNCaP/CH6M (siSlug) compared with non-targeting control siRNAtransfected cells (siScr; Figure 3B ,C). This suggests that slug plays a crucial role in increasing cell migration and invasion, which is induced by chronic hypoxia.
| Neither loss of E-cadherin expression nor induction of mesenchymal markers is observed in the LNCaP/CH6M cells
As mentioned herein, slug is a well-known EMT-driving transcription factor. 9 Therefore, to confirm that the EMT process was actually (>50% reduction). In other words, these genes correspond to the genes upregulated by chronic hypoxia-induced slug. We also chose genes specifically upregulated by chronic hypoxia (>2-fold increase)
by comparing the gene expression microarray data of LNCaP/N with that of LNCaP/CH6M. 23 From the list of the genes upregulated by slug as well as chronic hypoxia, we then selected genes known to be associated with cell migration and invasion using IPA (Table 1 ).
| Chronic hypoxia-induced ephrin-B1 promotes cell migration and invasion
Given that elevated expression of B-type ephrin (a ligand of Eph-related receptor tyrosine kinases) has been known to correlate with progression and metastasis in various cancers [27] [28] [29] and recent work suggests that the B-type ephrin-mediated signaling acts as a regulator of prostate development, 30 we decided to focus on EFNB1, which encodes an ephrin-B1 ligand F I G U R E 2 Chronic hypoxia specifically upregulates expression of an epithelialmesenchymal transition (EMT)-driving transcription factor slug. A, Fold change of expression levels of EMT-driving genes, snail, slug, Smuc, Twist1, and Twist2, in LNCaP under normoxic (N), acute hypoxic (AH), and chronic hypoxic (CH6M) conditions. B, Quantitative RT-PCR and C, western blot analysis of expression of snail and slug in LNCaP under the same conditions. B, Data given as mean ± SD. C, Total cell lysates of COS-7 and 293T were used as positive controls for snail and slug expression, respectively. β-Tubulin was used as a loading control F I G U R E 3 Knockdown of slug inhibits chronic hypoxia-induced cell migration and invasion. A, Western blot analysis of slug expression in the non-transfected (control), slug siRNA-transfected (siSlug), and control siRNA-transfected (siScr) LNCaP/CH6M cells. β-Tubulin was used as a loading control. B, Toluidine blue staining of the siRNA-transfected (control, siSlug, and siScr) LNCaP/CH6M cells that migrated to the undersurface of the membrane. C, Fold change of the number of cells that migrated or invaded to the undersurface of the membrane (n = 4). Data given as mean ± SD. *P < 0.05 (Table 1 ). First we confirmed that expression of ephrin-B1 is strongly upregulated under chronic hypoxia in LNCaP/CH6M
( Figure 5A ). EphB1, 2, 3, 4, and 6 are known to work as ephrin-B1 receptors. 31 We found that EphB2, 3, and 4 are preferentially expressed in LNCaP/CH6M and that expression of EphB4 is markedly induced under chronic hypoxia ( Figure S1 ). 
F I G U R E 4 Chronic hypoxia does not show epithelialmesenchymal transition-like features such as loss of E-cadherin. A, Western blot analysis of expression of E-cadherin, N-cadherin and vimentin in LNCaP cells under normoxic (N), acute hypoxic (AH)
, and chronic hypoxic (CH1M and CH6M) conditions. Total cell lysates of MCF7, 293T, and COS-7 were used as positive controls for Ecadherin, N-cadherin, and vimentin expression, respectively. B, Immunofluorescence staining of E-cadherin (green) and vimentin (red) in LNCaP cells under the same conditions. DAPI was used to stain nuclei (blue)
T A B L E 1 Chronic hypoxia-induced slug-upregulated genes associated with cell migration and invasion 
| Chronic hypoxia-induced slug activates expression of ephrin-B1 through E-box motifs
We next examined whether expression of the ephrin-B1 gene is actually activated by chronic hypoxia-induced slug in LNCaP/CH6M. Slug siRNA-transfected LNCaP/CH6M cells had a significantly decreased ephrin-B1 mRNA level (>50% reduction), while control siRNA had no detectable effect on ephrin-B1 mRNA level ( Figure 6A ). We further confirmed that ephrin-B1 mRNA was upregulated by forced expression of slug in a dose-dependent manner in LNCaP/N ( Figure 6B ). Slug functions either as an activator 20, [32] [33] [34] or a repressor [34] [35] [36] [37] by binding to an E-box, a sequence containing the CANNTG motif, in its target gene promoters. 20, 32, [35] [36] [37] We found 2 E-boxes at positions at −877 (E1) and −483 (E2) relative to the transcription start site (+1) of the ephrin-B1 gene ( Figure 6C ). To confirm that the E-boxes in the ephrin-B1 promoter are essential for the slug-mediated transactivation of ephrin-B1, we used the luciferase reporter plasmid containing the ephrin-B1 promoter sequence (from −1000 to +1 relative to the transcription start site, WT) and introduced mutations in either E-box1 or E-box2 as well
as both E-box1 and 2 (E1m, E2m, and E1mE2m, respectively) in the promoter ( Figure 6C ). 26 The LNCaP/N cells were co-transfected with the WT reporter plasmid and various amounts of the slug expression vector.
As expected, slug increased the ephrin-B1 promoter activity in a dosedependent manner ( Figure 6D ). Mutations of E-boxes in the promoter, E1m, E2m, and E1mE2m, led to an almost complete loss of slugmediated activation of the ephrin-B1 promoter ( Figure 6E ). Furthermore, we performed ChIP assays to investigate whether endogenous slug could be recruited to the E-box motifs in the ephrin-B1 promoter.
As shown in Figure 6F , slug indeed bound to both E-box-containing regions, but predominantly bound to the E-box1. Taken together, these results demonstrated that chronic hypoxia-induced slug activates the expression of ephrin-B1 through E-box motifs. ChIP was analyzed on quantitative PCR using primers flanking the E-box motifs, E-box1 and E-box2, shown in (C). Fold change compared with control IgG-enriched DNA fragments was measured. Data given as mean ± SD. *P < 0.05 F I G U R E 7 Slug and ephrin-B1 are coexpressed at a high level in human prostate adenocarcinoma cells after androgen deprivation therapy (ADT). A, Immunofluorescence of healthy and adenocarcinoma prostate tissues shows red staining for slug, green staining for ephrin-B1, and yellow fluorescence in the merged pictures for coexpression of slug and ephrin-B1. The tissues were counterstained with H&E and with DAPI. Representative immunofluorescence images of normal prostate tissues, low-grade and high-grade prostate adenocarcinomas, adenocarcinoma tissues and normal tissues adjacent to the cancerous region after ADT. Scale bar, 50 μm. B, Immunofluorescence of high-grade prostate adenocarcinoma tissues and normal tissues adjacent to the cancerous region after ADT shows red staining for ephrin-B1, green staining for carbonic anhydrase IX (CAIX), and yellow fluorescence in the merged pictures for coexpression of ephrin-B1 and CAIX. Scale bars, 50 μm observation is consistent with previous reports on the cytoplasmic expression of slug and ephrin-B1 in various cancers with poor prognosis. 28, [38] [39] [40] Furthermore, the expression of ephrin-B1 was induced in the cells expressing an endogenous marker of prolonged chronic hypoxia, carbonic anhydrase IX (CAIX) 41, 42 in adenocarcinoma tissues after ADT ( Figure 7B ). This suggests that coexpression of slug and ephrin-B1 is markedly induced in human prostate adenocarcinoma cells under the chronic hypoxic conditions caused by androgen deprivation.
| DISCUSSION
Solid tumors are exposed to hypoxic conditions over longer periods of time as they grow. 11, 12 The hypoxic condition contributes to the acquisition of the malignant phenotype including cell invasive behavior, but the effects of hypoxia on malignant progression have been mainly studied using tumor cells cultured under acute hypoxic conditions. [13] [14] [15] [16] [17] In this study, we demonstrated that chronic hypoxia promotes prostate cancer cell migration and invasion by upregulating the expression of an EMT-driving transcription factor, slug. Slug is widely known to work as a direct E-cadherin repressor, 36, 37 and its dysregulated expression correlates with poor clinical outcome in various types of cancers. [43] [44] [45] [46] We found that prostate cancer cells showed that the expression of HIF-1α is elevated under acute hypoxia, but it decreases to that observed under normoxia in the chronic hypoxic condition (unpublished data). Therefore, we speculate that upregulation of slug under chronic hypoxia may be controlled by transcription factors specifically induced under chronic hypoxia, rather than directly and solely by HIF-1α. We have found that knockdown of slug in the LNCaP/CH6M cells decreases the expression of a mitochondrial antioxidant, peroxiredoxin-3 (Prdx3),
suggesting that Prdx3 expression is upregulated by chronic hypoxia-induced slug (unpublished data). Overexpression of peroxiredoxins including Prdx3 has been reported in various cancers. 47 Furthermore, increased expression of Prdx3 has been known to protect cells from hypoxia-induced apoptosis. 48 Thus, it is presumed that overexpression of Prdx3 activated by chronic hypoxiainduced slug could confer anti-apoptotic properties to prostate cancer cells under chronic hypoxia.
Given that the growth of prostate cancer cells depends on androgens and androgen receptor (AR) signaling, ADT is widely used for the treatment of locally advanced and metastatic disease.
ADT initially controls the growth of androgen-dependent tumors, but eventually the majority of these tumors progress to more aggressive and metastatic castration-resistant tumors. 49, 50 Docetaxel has been used as the standard chemotherapeutic drug for metastatic castration-resistant cancers, but resistance eventually occurs through a number of mechanisms, including activation of prosurvival signaling, increased drug-efflux, and overexpression of β-tubulin isoforms and inflammation-associated molecules. 51, 52 Although many novel agents designed to overcome chemoresistance are currently under development, the prognosis of castration-resistant cancers remains poor. 53 It is noteworthy that ephrin-B1 expression is strongly induced after ADT of prostate adenocarcinoma cells and, perhaps more importantly, ADT does not induce ephrin-B1 expression in normal tissue adjacent to the cancerous region. This suggests that ephrin-B1 may be a novel promising therapeutic target with a low risk of local toxicity in healthy tissue, in combination with ADT or as adjuvant treatment after ADT for aggressive prostate cancers.
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